Literature DB >> 15563971

An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea.

D M Kim1, C W Ahn, J S Park, B S Cha, S K Lim, K R Kim, H C Lee, K B Huh.   

Abstract

This study was undertaken to investigate diverse risk factors affecting the progression of diabetic nephropathy (DN) by observing the changes of 24 h urinary albumin excretion (24 h UAE) in 90 abdominally obese, normal weight, type 2 diabetic patients with normo- or micro-albuminuria. Patients were divided into three groups according to the 24h UAE; normo-, micro-, and macro-albuminuria group. After 4 years of follow-up, patients were divided into either progression or non-progression group according to the changes of 24 h UAE. About 37% of the normo-albuminuria group and 18% of the micro-albumiuria group were classified into the progression group. The initial serum creatinine levels and the initial and follow-up post-prandial plasma glucose levels were significantly higher in the progression group than in the non-progression group. Most remarkably, the initial and follow-up serum triglyceride (TG) levels (190 +/- 132 versus 132 +/- 49 mg/dl and 191 +/- 124 versus 133 +/- 41 mg/dl, P < 0.01 in both) were significantly higher in the progression group than in the non-progression group, suggesting hypertriglyceridemia might be included in the progression factors of DN. The increases in 24-hour UAE were positively associated with the initial and follow-up post-prandial plasma glucose levels (P < 0.05 in both), the initial and follow-up serum creatinine levels (P < 0.05 in both), and the initial serum TG levels (P < 0.05). Whereas, insulin users or patients with retinopathy at follow-up (P < 0.05 in both) showed more rapid progression of albuminuria, ACE inhibitors or acarbose (P < 0.05 in both) use turned out to protect against it.

Entities:  

Mesh:

Year:  2004        PMID: 15563971     DOI: 10.1016/j.diabres.2004.07.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

1.  Triglycerides are independently associated with albuminuria in Taiwanese Type 2 diabetic patients.

Authors:  K-J Tien; S-T Tu; H-C Chen; J-Y Hsiao; M-C Hsieh
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

2.  Relationship between dyslipidemia and albuminuria in prediabetic adults: the Korea National Health and Nutrition Examination Survey 2011-2012.

Authors:  Ga Eun Nam; Kyungdo Han; Do Hoon Kim; Yong Gyu Park; Yeo Joon Yoon; Young Eun Kim; Sangsu Lee; Sungho Lee; Yong Kyun Roh
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

3.  Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.

Authors:  Liang He; Lili Hao; Xin Fu; Mingshu Huang; Rui Li
Journal:  BMC Nephrol       Date:  2015-04-11       Impact factor: 2.388

4.  Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial.

Authors:  Qingrong Pan; Yuan Xu; Ning Yang; Xia Gao; Jia Liu; Wenying Yang; Guang Wang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy.

Authors:  Kyung Jin Yun; Hye Ji Kim; Mee Kyoung Kim; Hyuk Sang Kwon; Ki Hyun Baek; Young Jung Roh; Ki Ho Song
Journal:  Diabetes Metab J       Date:  2016-09-20       Impact factor: 5.376

6.  Risk factors for subclinical renal damage and its progression: Hanzhong Adolescent Hypertension Study.

Authors:  Yang Wang; Ming-Fei Du; Wei-Hua Gao; Bo-Wen Fu; Qiong Ma; Yu Yan; Yue Yuan; Chao Chu; Chen Chen; Yue-Yuan Liao; Ke Gao; Ke-Ke Wang; Min Li; Yue Sun; Jia-Wen Hu; Xin Chen; Qiong Ma; Dan Wang; Xiao-Yu Zhang; Chun-Hua Li; Hao-Wei Zhou; Wan-Hong Lu; Zu-Yi Yuan; John Chang; Jian-Jun Mu
Journal:  Eur J Clin Nutr       Date:  2020-09-29       Impact factor: 4.016

Review 7.  On the potential of acarbose to reduce cardiovascular disease.

Authors:  Eberhard Standl; Michael J Theodorakis; Michael Erbach; Oliver Schnell; Jaakko Tuomilehto
Journal:  Cardiovasc Diabetol       Date:  2014-04-16       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.